Superficial pyodermas: Advances, recommendations and needs

Dermatology

Volumn 210, Issue 4, 2005, Pages 367-369

  Del Giudice, P ^a   Chosidow, O ^b  

^a Hopital Bonnet   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antibiotic resistance; Folliculitis; Group A haemolytic streptococcus; Impetigo; Macrolides; Oxacillin; Pristinamycin; Pyoderma; Staphylococcus aureus

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CHLORHEXIDINE; CLOXACILLIN; ERYTHROMYCIN; FUSIDIC ACID; MACROLIDE; POVIDONE IODINE; PRISTINAMYCIN; PSEUDOMONIC ACID;

DERMATOLOGY; DRUG BIOAVAILABILITY; DRUG EFFICACY; EDITORIAL; HEMOLYSIS; INFECTION RISK; PRIORITY JOURNAL; PYODERMA; RISK FACTOR; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; TISSUE NECROSIS;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FRANCE; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; INCIDENCE; MALE; PRACTICE GUIDELINES; PROGNOSIS; PYODERMA; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL SKIN INFECTIONS; TREATMENT OUTCOME;

EID: 22144473339     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085112     Document Type: Editorial

References (21)

1. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998;339:520-532.
2. Couppie P, Cribier B, Prevost G: Leukocidin from Staphylococcus aureus and cutaneous infections: An epidemiologic study. Arch Dermatol 1994;130:1208-1209.
3. Gillet Y, Issartel B, Vanhems P, et al: Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002;35:753-759.
4. Hanakawa Y, Schechter NM, Lin C, et al: Molecular mechanisms of blister formation in bullous impetigo and staphylococcal scalded skin syndrome. J Clin Invest 2002;110:53-60.
5. Amagai M, Matsuyoshi N, Wang ZH, Andl C, Stanley JR: Toxin in bullous impetigo and staphylococcal scalded-skin syndrome targets desmoglein 1. Nat Med 2000;6:1275-1277.
6. Chosidow O, Bernard P, Berbis P, Humbert P, Crickx B, Jarlier V: Cloxacillin versus pristinamycin for superficial pyodermas: A randomized, open-label, non-inferiority study. Dermatology 2005;210:370-374.
7. Koning S, van der Wouden JC: Treatment for impetigo. BMJ 2004;329;695-696.
8. George A, Rubin G: A systematic review and meta-analysis of treatments for impetigo. Br J Gen Pract 2003;53:480-487.
9. http://agmed.sante.gouv.fr/. Prescription des antibiotiques par voie locale dans les infections cutanées primitives et secondaires, July 2004.
10. Naimi TS, LeDell KH, Como-Sabetti K, et al: Comparison of community and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003;290:2976-2984.
11. Vandenesch F, Naimi T, Enright MC, et al: Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence. Emerg Infect Dis 2003;9:978-984.
12. Salgado CD, Farr BM, Calfee DP: Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-139.
13. Lina G, Piemont Y, Godail-Gamot F, et al: Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999;29:1128-1132.
14. Cohen PR, Kurzrock R: Community-acquired methicillin-resistant Staphylococcus aureus skin infection: An emerging clinical problem. J Am Acad Dermatol 2004;50:277-280.
15. Iyer S, Jones DH: Community-acquired methicillin-resistant Staphylococcus skin infection: A retrospective analysis of clinical presentation and treatment of a local outbreak. J Am Acad Dermatol 2004;50:854-858.
16. Yamaguchi T, Yokota Y, Terajima J, et al: Clonal association of Staphylococcus aureus causing bullous impetigo and the emergence of new methicillin-resistant clonal groups in Kansai district of Japan. J Infect Dis 2002;185:1511-1516.
17. Liassine N, Auckenthaler R, Descombes MC, Bès M, Vandenesch F, Etienne J: Community-acquired methicillin-resistant Staphylococcus aureus isolated in Switzerland contains the Panton-Valentine leukocidin or exfoliative toxin genes. J Clin Microbiol 2004;42:825-828.
18. Kazakova SV, Hageman JC, Matava M, et al: A clone of methicillin- resistant Staphylococcus aureus among professional football players. N Engl J Med 2005;352:468-475.
19. Martin JM, Green M, Barbadora KA, Wald ER: Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med 2002;346:1200-1206.
20. Seppala H, Klaukka T, Vuopio-Varkila J, Muotiala A, Helenius H, Lager K, Huovinen P: The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance. N Engl J Med 1997;337:441-446.
21. Ray WA, Murray KT, Meredith S, Narasimhulu SS, Hall K, Stein CM: Oral erythromycin and the risk of sudden death from cardiac causes. N Engl J Med 2004;351:1089-1096.